Citigroup’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Citigroup’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-281,100	Closed	-$28.8M	–	7819
2014 Q4	$28.8M	Sell	281,100 -98,100	-26%	-$9.41M	0.03%	628
2014 Q3	$32.8M	Sell	379,200 -43,800	-10%	-$3.88M	0.03%	556
2014 Q2	$38.1M	Buy	423,000 +358,300	+554%	+$26.8M	0.04%	453
2014 Q1	$4.77M	Sell	64,700 -53,400	-45%	-$3.72M	﹤0.01%	1740
2013 Q4	$8.04M	Sell	118,100 -35,500	-23%	-$2.31M	0.01%	1412
2013 Q3	$9.36M	Buy	153,600 +89,417	+139%	+$5.46M	0.01%	1224
2013 Q2	$3.58M	Buy	+64,183	New	+$3.71M	﹤0.01%	1933

Citigroup's COV Position: Q1 2015 in Review

Citigroup sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 2,729,185 shares — an estimated $279M sold.

Citigroup first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $279M in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

Citigroup reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
Citigroup sold 2,729,185 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $279M.
Citigroup first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
Citigroup's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $279M in Q4 2014.
1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Citigroup's 13F filing for Q1 2015, filed 14 May 2015.